Unlocking the Power of Genomics: An Interview with Genetic Technologies' CEO Simon Morriss
Genetic Technologies Limited (Nasdaq: GENE) is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellness and serious disease through its geneType and EasyDNA brands. GTG offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The company has a proprietary risk stratification platform that has been developed over the past decade and integrates clinical and genetic risk to deliver actionable outcomes to physicians and individuals. Leading the world in risk prediction in oncology, cardiovascular and metabolic diseases, Genetic Technologies continues to develop risk assessment products. Learn more at www.genetechinfo.com.
0:00 - Start
0:05 - Company Overview
1:10 - Market Opportunity
1:58 - Planned Pilot Program
2:45 - Business Model
3:44 - Management Team
5:08 - Value Proposition
-
0:20
RedChip
1 year agoGenetic Technologies: A Global Leader in Genomics-Based Risk Prediction
3 -
2:36
RedChip
9 months agoGenetic Technologies: Decoding the Genome and Unlocking its Value for Human Health
5 -
5:48
AJHealth
3 months agoThe Impact of Genetics on Health An In Depth Exploration
23 -
2:32
Asher Press
1 year agoSenator Gerard Rennick: The TGA Didn't Consult with the Gene Tech Regulator 02.16.2023
114 -
56:40
ProgressPotentialAndPossibilities
11 months agoDr. Brad Ringeisen, Ph.D. - Executive Director, Innovative Genomics Institute (IGI)
27 -
0:39
FGP
3 months ago🧬 Unlocking The Genetic Code 🔬
42 -
39:18
The Official Corbett Report Rumble Channel
1 year agoGuess Who's Funding and Promoting Gene Drives...
84 -
4:16
ScienceManiatics
1 year agoThe FIRST CRISPR Gene Edited Meat CEO is RESETTING SCIENCE!!!
111 -
4:41
ADVANCED CIVILIZATION
10 months agoScientists Control Human DNA Using Electricity
81 -
4:20
Hot_Topic
4 months agoWhen safety testing is skipped and a novel genetic technology is
157